HomeEnClear Therapies

EnClear Therapies

Medical Device Developer EnClear Therapies Spins out of QurAlis

12/28/18: “During our discovery process of causative gene mutations in ALS, we realized that some of the mutated proteins transcribed from these genes cause not only loss of function issues but that the mutations make them in fact specifically toxic and that this toxicity spreads through the brain and spinal cord causing neuronal death,” said Kasper Roet, Ph.D., CEO of QurAlis and Co-Founder of EnClear.